Authors
Loading...
Does not support changing post-MI valsartan use; leaves open periostin as a remodeling target for future therapies.
Iekushi et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: